Thyroseq V3 molecular testing for fine needle aspiration biopsy samples of thyroid nodules
The National Institutes of Health (NIH) seeks to award a Firm-Fixed-Price contract for Thyroseq testing on 20 nodules per year for fiscal year 2026. This is a competitive, full-and-open procurement with an estimated value not expected to exceed the simplified acquisition threshold of $350,000. The government will evaluate offers based on technical capability, price, past performance, and delivery schedule. All responses must be received by July 27, 2026, at 9:00 AM. The location for performance of services is not specified.